Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02021383 · ClinicalTrials.gov registry record · NA

Lose 2 Win A Novel Method to Motivate Weight Loss Maintenance Among College Students

A NA study, sponsored by University of Minnesota.

Completed
Registry status
NA
Development phase
144
Enrollment target

NCT02021383: Completed NA study, sponsored by University of Minnesota.

NCT02021383 is a NA study that has completed, run by University of Minnesota. The registered enrollment target is 144 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02021383, a NA study, has completed, sponsored by University of Minnesota.

COMPLETED
Registry status
NA
Development phase
144 participants
Enrollment target

Study Summary

Investigators are conducting a randomized controlled trial with overweight and obese college students on the University of Minnesota campus. The primary outcome will be weight loss measured 12 months after study enrollment (corresponds to 10 months after the end of treatment).

Interventions

  • BEHAVIORAL Bi-weekly in person meetings with a Registered Dietician
  • BEHAVIORAL Financial incentives for weight loss maintenance

Trial Details

FieldValue
Enrollment Target 144 participants
Start Date 2012-03-01
Est. Completion 2014-02-28
Phase NA
University of Minnesota

966 total trials

What the finished NCT02021383 record still lists

NCT02021383 is an interventional study that assigns participants to a tested intervention. The registered 144 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).

The record links to 0 conditions, and to 2 interventions - of which Bi-weekly in person meetings with a Registered Dietician is the first listed.

NCT02021383 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02021383 about?

NCT02021383 is a clinical study titled "Lose 2 Win A Novel Method to Motivate Weight Loss Maintenance Among College Students". Investigators are conducting a randomized controlled trial with overweight and obese college students on the University of Minnesota campus. The primary outcome will be weight loss measured 12 months after study enrollment (corresponds to 10 months after the end of treatment).

What is the current status of trial NCT02021383?

This trial is currently completed. It is a NA study. The enrollment target is 144 participants. The study started on 2012-03-01. Estimated completion is 2014-02-28.

What interventions are being tested in trial NCT02021383?

The interventions under investigation include: Bi-weekly in person meetings with a Registered Dietician (BEHAVIORAL), Financial incentives for weight loss maintenance (BEHAVIORAL).

Who is sponsoring clinical trial NCT02021383?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02021383's enrollment target sits among peer trials

144 706th of 2000 higher than 1,290 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01861106 · 144 participants · Phase 2

    Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations

  • NCT03482245 · 144 participants · NA

    The Role of Circadian Clock Proteins in Innate and Adaptive Immunity

  • NCT03504683 · 144 participants · NA

    MEAL TIMING Study: Effect of Time-Restricted Feeding on 24-hour Glycemic Control, Blood Pressure, and Cardiovascular Disease Risk Factors in Adults With Prediabetes

  • NCT03905603 · 144 participants · Early Phase 1

    Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOS

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02021383, the US trial registry maintained by the National Library of Medicine. NCT02021383 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.